为早期乳腺癌女性定制局部和全身治疗:2021年圣加仑国际早期乳腺癌治疗共识指南
第17届圣加仑国际乳腺癌共识会议于2021年以虚拟形式召开,来自各大洲的74位专家组成员讨论了早期乳腺癌诊断和治疗的关键问题,会议主题为「定制局部和全身治疗」。共识强调乳腺癌治疗依赖于高度个体化的临床特征,包括分期、生物学亚型、遗传因素、基因组特征、新辅助治疗后的反应程度和患者偏好,需要影像、病理、遗传、外科、内科和放射肿瘤等多学科协作。
要点
- 早期乳腺癌治疗需基于分期、生物学亚型、遗传和基因组特征等高度个体化临床特征定制方案。
- 新辅助治疗后手术前反应程度是定制治疗决策的重要依据之一。
- 个体化治疗需要影像、病理、遗传、外科、内科和放射肿瘤等多学科动态协作。
核心结论
- 早期乳腺癌的局部和全身治疗应基于高度个体化的临床特征进行定制,并需要多学科团队在诊断和治疗全程中动态整合信息。
研究设计与样本
- 第17届圣加仑国际乳腺癌共识会议因COVID-19全球大流行以虚拟形式召开,超过3300名参会者,74位来自各大洲的专家组成员参与讨论和评论预先拟定的共识问题及听众提出的关键问题,会议包括预录研讨会、现场小组讨论和实时小组投票。
临床应用与阅片要点
- 原文未据此给出具体的影像阅片或报告推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The 17th St Gallen International Breast Cancer Consensus Conference in 2021 was held virtually, owing to the global COVID-19 pandemic. More than 3300 participants took part in this important bi-annual critical review of the 'state of the art' in the multidisciplinary care of early-stage breast cancer. Seventy-four expert panelists (see Appendix 1) from all continents discussed and commented on the previously elaborated consensus questions, as well as many key questions on early breast cancer diagnosis and treatment asked by the audience. The theme of this year's conference was 'Customizing local and systemic therapies.' A well-organized program of pre-recorded symposia, live panel discussions and real-time panel voting results drew a worldwide audience of thousands, reflecting the far-reaching impact of breast cancer on every continent. The interactive technology platform allowed, for the first time, audience members to ask direct questions to panelists, and to weigh in with their own vote on several key panel questions. A hallmark of this meeting was to focus on customized recommendations for treatment of early-stage breast cancer. There is increasing recognition that the care of a breast cancer patient depends on highly individualized clinical features, including the stage at presentation, the biological subset of breast cancer, the genetic factors that may underlie breast cancer risk, the genomic signatures that inform treatment recommendations, the extent of response before surgery in patients who receive neoadjuvant therapy, and patient preferences. This customized approach to treatment requires integration of clinical care between patients and radiology, pathology, genetics, and surgical, medical and radiation oncology providers. It also requires a dynamic response from clinicians as they encounter accumulating clinical information at the time of diagnosis and then serially with each step in the treatment plan and follow-up, reflecting patient experiences and treatment response.
引用
- Burstein HJ, Curigliano G, Thürlimann B, et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021. PMID: 34242744. doi:10.1016/j.annonc.2021.06.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。